Federico Grossi is Chief Medical Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 94,884 shares of APLS, which is worth approximately $3.1 Million. The most recent transaction as insider was on Jan 04, 2021, when has been sold 600 shares (Common Stock) at a price of $57.24 per share, resulting in proceeds of $34,344. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.9K
0% 3M change
0% 12M change
Total Value Held $3.1 Million

Federico Grossi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2021
SELL
Open market or private sale
$34,344 $57.24 p/Share
600 Reduced 1.48%
39,827 Common Stock
Dec 04 2020
BUY
Exercise of conversion of derivative security
$23,200 $3.2 p/Share
7,250 Added 15.21%
40,427 Common Stock
Dec 01 2020
SELL
Open market or private sale
$28,950 $48.25 p/Share
600 Reduced 1.78%
33,177 Common Stock
Nov 16 2020
BUY
Exercise of conversion of derivative security
$18,400 $3.2 p/Share
5,750 Added 14.55%
33,777 Common Stock
Nov 02 2020
SELL
Open market or private sale
$18,654 $31.09 p/Share
600 Reduced 2.12%
27,725 Common Stock
Oct 01 2020
SELL
Open market or private sale
$18,132 $30.22 p/Share
600 Reduced 2.07%
28,325 Common Stock
FG

Federico Grossi

Chief Medical Officer
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS